NCT05361798: A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Cancer Of Prostate